These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 11366790)
1. Are changes in body shape due to drug side effects? TreatmentUpdate; 1999 Jun; 11(4):3-4. PubMed ID: 11366790 [TBL] [Abstract][Full Text] [Related]
2. Are changes in body shape linked to viral load. TreatmentUpdate; 1999 Jun; 11(4):4-5. PubMed ID: 11366791 [TBL] [Abstract][Full Text] [Related]
3. Fat, sugar and drugs on the French Riviera. Lands L GMHC Treat Issues; 1999 Mar; 13(3):9-11. PubMed ID: 11366205 [TBL] [Abstract][Full Text] [Related]
4. Lipodrama. Horn T Res Initiat Treat Action; 1999 Dec; 5(5):13-5. PubMed ID: 11366885 [TBL] [Abstract][Full Text] [Related]
9. Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up. Negredo E; Paredes R; Bonjoch A; Tuldrà A; Fumaz CR; Gel S; Garcés B; Johnston S; Arnó A; Balagué M; Jou A; Tural C; Sirera G; Romeu J; Cruz L; Francia E; Domingo P; Arrizabalaga J; Ruiz I; Arribas JR; Ruiz L; Clotet B Antivir Ther; 1999; 4 Suppl 3():23-8. PubMed ID: 16021868 [TBL] [Abstract][Full Text] [Related]
10. Toxicity of antiretroviral therapy and implications for drug development. Carr A Nat Rev Drug Discov; 2003 Aug; 2(8):624-34. PubMed ID: 12904812 [No Abstract] [Full Text] [Related]
11. Transfer therapy--Nevirapine for protease problems? TreatmentUpdate; 1999 Jun; 11(4):6-7. PubMed ID: 11366793 [TBL] [Abstract][Full Text] [Related]
12. Protease inhibitors and body shape changes. TreatmentUpdate; 1998 Apr; 10(2):4-5. PubMed ID: 11365437 [TBL] [Abstract][Full Text] [Related]
14. New antiretroviral drugs part I: PIs. Murphy RL AIDS Clin Care; 1999 May; 11(5):35-7. PubMed ID: 11367101 [TBL] [Abstract][Full Text] [Related]
15. Lipodystrophy in patients with HIV-1 infection: effect of stopping protease inhibitors on TNF-alpha and TNF-receptor levels, and on metabolic parameters. Maher B; Lloyd J; Wilkins EG; Fraser WD; Back D; Park BK; Pirmohamed M Antivir Ther; 2004 Dec; 9(6):879-87. PubMed ID: 15651746 [TBL] [Abstract][Full Text] [Related]